Pediatric ADHD Drugs and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Pediatric ADHD Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pediatric ADHD Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pediatric ADHD Drugs Overall Market Size
2.1 Global Pediatric ADHD Drugs Market Size: 2022 VS 2029
2.2 Global Pediatric ADHD Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Pediatric ADHD Drugs Players in Global Market
3.2 Top Global Pediatric ADHD Drugs Companies Ranked by Revenue
3.3 Global Pediatric ADHD Drugs Revenue by Companies
3.4 Top 3 and Top 5 Pediatric ADHD Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Pediatric ADHD Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pediatric ADHD Drugs Players in Global Market
3.6.1 List of Global Tier 1 Pediatric ADHD Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Pediatric ADHD Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Pediatric ADHD Drugs Market Size Markets, 2022 & 2029
4.1.2 Tablets
4.1.3 Oral Liquid
4.1.4 Other
4.2 By Type - Global Pediatric ADHD Drugs Revenue & Forecasts
4.2.1 By Type - Global Pediatric ADHD Drugs Revenue, 2018-2023
4.2.2 By Type - Global Pediatric ADHD Drugs Revenue, 2024-2029
4.2.3 By Type - Global Pediatric ADHD Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pediatric ADHD Drugs Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.1.4 Other
5.2 By Application - Global Pediatric ADHD Drugs Revenue & Forecasts
5.2.1 By Application - Global Pediatric ADHD Drugs Revenue, 2018-2023
5.2.2 By Application - Global Pediatric ADHD Drugs Revenue, 2024-2029
5.2.3 By Application - Global Pediatric ADHD Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Pediatric ADHD Drugs Market Size, 2022 & 2029
6.2 By Region - Global Pediatric ADHD Drugs Revenue & Forecasts
6.2.1 By Region - Global Pediatric ADHD Drugs Revenue, 2018-2023
6.2.2 By Region - Global Pediatric ADHD Drugs Revenue, 2024-2029
6.2.3 By Region - Global Pediatric ADHD Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Pediatric ADHD Drugs Revenue, 2018-2029
6.3.2 US Pediatric ADHD Drugs Market Size, 2018-2029
6.3.3 Canada Pediatric ADHD Drugs Market Size, 2018-2029
6.3.4 Mexico Pediatric ADHD Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Pediatric ADHD Drugs Revenue, 2018-2029
6.4.2 Germany Pediatric ADHD Drugs Market Size, 2018-2029
6.4.3 France Pediatric ADHD Drugs Market Size, 2018-2029
6.4.4 U.K. Pediatric ADHD Drugs Market Size, 2018-2029
6.4.5 Italy Pediatric ADHD Drugs Market Size, 2018-2029
6.4.6 Russia Pediatric ADHD Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Pediatric ADHD Drugs Market Size, 2018-2029
6.4.8 Benelux Pediatric ADHD Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Pediatric ADHD Drugs Revenue, 2018-2029
6.5.2 China Pediatric ADHD Drugs Market Size, 2018-2029
6.5.3 Japan Pediatric ADHD Drugs Market Size, 2018-2029
6.5.4 South Korea Pediatric ADHD Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Pediatric ADHD Drugs Market Size, 2018-2029
6.5.6 India Pediatric ADHD Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Pediatric ADHD Drugs Revenue, 2018-2029
6.6.2 Brazil Pediatric ADHD Drugs Market Size, 2018-2029
6.6.3 Argentina Pediatric ADHD Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Pediatric ADHD Drugs Revenue, 2018-2029
6.7.2 Turkey Pediatric ADHD Drugs Market Size, 2018-2029
6.7.3 Israel Pediatric ADHD Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Pediatric ADHD Drugs Market Size, 2018-2029
6.7.5 UAE Pediatric ADHD Drugs Market Size, 2018-2029
7 Pediatric ADHD Drugs Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Pediatric ADHD Drugs Major Product Offerings
7.1.4 Pfizer Pediatric ADHD Drugs Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Company Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Pediatric ADHD Drugs Major Product Offerings
7.2.4 Johnson & Johnson Pediatric ADHD Drugs Revenue in Global Market (2018-2023)
7.2.5 Johnson & Johnson Key News & Latest Developments
7.3 Eli Lilly and Company
7.3.1 Eli Lilly and Company Company Summary
7.3.2 Eli Lilly and Company Business Overview
7.3.3 Eli Lilly and Company Pediatric ADHD Drugs Major Product Offerings
7.3.4 Eli Lilly and Company Pediatric ADHD Drugs Revenue in Global Market (2018-2023)
7.3.5 Eli Lilly and Company Key News & Latest Developments
7.4 Tris Pharma
7.4.1 Tris Pharma Company Summary
7.4.2 Tris Pharma Business Overview
7.4.3 Tris Pharma Pediatric ADHD Drugs Major Product Offerings
7.4.4 Tris Pharma Pediatric ADHD Drugs Revenue in Global Market (2018-2023)
7.4.5 Tris Pharma Key News & Latest Developments
7.5 Noven Pharmaceuticals
7.5.1 Noven Pharmaceuticals Company Summary
7.5.2 Noven Pharmaceuticals Business Overview
7.5.3 Noven Pharmaceuticals Pediatric ADHD Drugs Major Product Offerings
7.5.4 Noven Pharmaceuticals Pediatric ADHD Drugs Revenue in Global Market (2018-2023)
7.5.5 Noven Pharmaceuticals Key News & Latest Developments
7.6 Alcobra Pharmaceuticals
7.6.1 Alcobra Pharmaceuticals Company Summary
7.6.2 Alcobra Pharmaceuticals Business Overview
7.6.3 Alcobra Pharmaceuticals Pediatric ADHD Drugs Major Product Offerings
7.6.4 Alcobra Pharmaceuticals Pediatric ADHD Drugs Revenue in Global Market (2018-2023)
7.6.5 Alcobra Pharmaceuticals Key News & Latest Developments
7.7 Novartis
7.7.1 Novartis Company Summary
7.7.2 Novartis Business Overview
7.7.3 Novartis Pediatric ADHD Drugs Major Product Offerings
7.7.4 Novartis Pediatric ADHD Drugs Revenue in Global Market (2018-2023)
7.7.5 Novartis Key News & Latest Developments
7.8 GlaxoSmithKline
7.8.1 GlaxoSmithKline Company Summary
7.8.2 GlaxoSmithKline Business Overview
7.8.3 GlaxoSmithKline Pediatric ADHD Drugs Major Product Offerings
7.8.4 GlaxoSmithKline Pediatric ADHD Drugs Revenue in Global Market (2018-2023)
7.8.5 GlaxoSmithKline Key News & Latest Developments
7.9 Purdue Pharma
7.9.1 Purdue Pharma Company Summary
7.9.2 Purdue Pharma Business Overview
7.9.3 Purdue Pharma Pediatric ADHD Drugs Major Product Offerings
7.9.4 Purdue Pharma Pediatric ADHD Drugs Revenue in Global Market (2018-2023)
7.9.5 Purdue Pharma Key News & Latest Developments
7.10 Takeda Pharmaceutical
7.10.1 Takeda Pharmaceutical Company Summary
7.10.2 Takeda Pharmaceutical Business Overview
7.10.3 Takeda Pharmaceutical Pediatric ADHD Drugs Major Product Offerings
7.10.4 Takeda Pharmaceutical Pediatric ADHD Drugs Revenue in Global Market (2018-2023)
7.10.5 Takeda Pharmaceutical Key News & Latest Developments
7.11 Curemark
7.11.1 Curemark Company Summary
7.11.2 Curemark Business Overview
7.11.3 Curemark Pediatric ADHD Drugs Major Product Offerings
7.11.4 Curemark Pediatric ADHD Drugs Revenue in Global Market (2018-2023)
7.11.5 Curemark Key News & Latest Developments
7.12 Supernus Pharmaceuticals
7.12.1 Supernus Pharmaceuticals Company Summary
7.12.2 Supernus Pharmaceuticals Business Overview
7.12.3 Supernus Pharmaceuticals Pediatric ADHD Drugs Major Product Offerings
7.12.4 Supernus Pharmaceuticals Pediatric ADHD Drugs Revenue in Global Market (2018-2023)
7.12.5 Supernus Pharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Pediatric ADHD Drugs Market Opportunities & Trends in Global Market
Table 2. Pediatric ADHD Drugs Market Drivers in Global Market
Table 3. Pediatric ADHD Drugs Market Restraints in Global Market
Table 4. Key Players of Pediatric ADHD Drugs in Global Market
Table 5. Top Pediatric ADHD Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Pediatric ADHD Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Pediatric ADHD Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Pediatric ADHD Drugs Product Type
Table 9. List of Global Tier 1 Pediatric ADHD Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pediatric ADHD Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Pediatric ADHD Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Pediatric ADHD Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Pediatric ADHD Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Pediatric ADHD Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Pediatric ADHD Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Pediatric ADHD Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Pediatric ADHD Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Pediatric ADHD Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Pediatric ADHD Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Pediatric ADHD Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Pediatric ADHD Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Pediatric ADHD Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Pediatric ADHD Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Pediatric ADHD Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Pediatric ADHD Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Pediatric ADHD Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Pediatric ADHD Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Pediatric ADHD Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Pediatric ADHD Drugs Revenue, (US$, Mn), 2024-2029
Table 30. Pfizer Company Summary
Table 31. Pfizer Pediatric ADHD Drugs Product Offerings
Table 32. Pfizer Pediatric ADHD Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer Key News & Latest Developments
Table 34. Johnson & Johnson Company Summary
Table 35. Johnson & Johnson Pediatric ADHD Drugs Product Offerings
Table 36. Johnson & Johnson Pediatric ADHD Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Johnson & Johnson Key News & Latest Developments
Table 38. Eli Lilly and Company Company Summary
Table 39. Eli Lilly and Company Pediatric ADHD Drugs Product Offerings
Table 40. Eli Lilly and Company Pediatric ADHD Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Eli Lilly and Company Key News & Latest Developments
Table 42. Tris Pharma Company Summary
Table 43. Tris Pharma Pediatric ADHD Drugs Product Offerings
Table 44. Tris Pharma Pediatric ADHD Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Tris Pharma Key News & Latest Developments
Table 46. Noven Pharmaceuticals Company Summary
Table 47. Noven Pharmaceuticals Pediatric ADHD Drugs Product Offerings
Table 48. Noven Pharmaceuticals Pediatric ADHD Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Noven Pharmaceuticals Key News & Latest Developments
Table 50. Alcobra Pharmaceuticals Company Summary
Table 51. Alcobra Pharmaceuticals Pediatric ADHD Drugs Product Offerings
Table 52. Alcobra Pharmaceuticals Pediatric ADHD Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Alcobra Pharmaceuticals Key News & Latest Developments
Table 54. Novartis Company Summary
Table 55. Novartis Pediatric ADHD Drugs Product Offerings
Table 56. Novartis Pediatric ADHD Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Novartis Key News & Latest Developments
Table 58. GlaxoSmithKline Company Summary
Table 59. GlaxoSmithKline Pediatric ADHD Drugs Product Offerings
Table 60. GlaxoSmithKline Pediatric ADHD Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. GlaxoSmithKline Key News & Latest Developments
Table 62. Purdue Pharma Company Summary
Table 63. Purdue Pharma Pediatric ADHD Drugs Product Offerings
Table 64. Purdue Pharma Pediatric ADHD Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Purdue Pharma Key News & Latest Developments
Table 66. Takeda Pharmaceutical Company Summary
Table 67. Takeda Pharmaceutical Pediatric ADHD Drugs Product Offerings
Table 68. Takeda Pharmaceutical Pediatric ADHD Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Takeda Pharmaceutical Key News & Latest Developments
Table 70. Curemark Company Summary
Table 71. Curemark Pediatric ADHD Drugs Product Offerings
Table 72. Curemark Pediatric ADHD Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. Curemark Key News & Latest Developments
Table 74. Supernus Pharmaceuticals Company Summary
Table 75. Supernus Pharmaceuticals Pediatric ADHD Drugs Product Offerings
Table 76. Supernus Pharmaceuticals Pediatric ADHD Drugs Revenue (US$, Mn) & (2018-2023)
Table 77. Supernus Pharmaceuticals Key News & Latest Developments
List of Figures
Figure 1. Pediatric ADHD Drugs Segment by Type in 2022
Figure 2. Pediatric ADHD Drugs Segment by Application in 2022
Figure 3. Global Pediatric ADHD Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Pediatric ADHD Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Pediatric ADHD Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pediatric ADHD Drugs Revenue in 2022
Figure 8. By Type - Global Pediatric ADHD Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Pediatric ADHD Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Pediatric ADHD Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Pediatric ADHD Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Pediatric ADHD Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Pediatric ADHD Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Pediatric ADHD Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Pediatric ADHD Drugs Revenue Market Share, 2018-2029
Figure 16. US Pediatric ADHD Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Pediatric ADHD Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Pediatric ADHD Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Pediatric ADHD Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Pediatric ADHD Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Pediatric ADHD Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Pediatric ADHD Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Pediatric ADHD Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Pediatric ADHD Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Pediatric ADHD Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Pediatric ADHD Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Pediatric ADHD Drugs Revenue Market Share, 2018-2029
Figure 28. China Pediatric ADHD Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Pediatric ADHD Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Pediatric ADHD Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Pediatric ADHD Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Pediatric ADHD Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Pediatric ADHD Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Pediatric ADHD Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Pediatric ADHD Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Pediatric ADHD Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Pediatric ADHD Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Pediatric ADHD Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Pediatric ADHD Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Pediatric ADHD Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. Pfizer Pediatric ADHD Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Johnson & Johnson Pediatric ADHD Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Eli Lilly and Company Pediatric ADHD Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Tris Pharma Pediatric ADHD Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Noven Pharmaceuticals Pediatric ADHD Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Alcobra Pharmaceuticals Pediatric ADHD Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Novartis Pediatric ADHD Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. GlaxoSmithKline Pediatric ADHD Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Purdue Pharma Pediatric ADHD Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Takeda Pharmaceutical Pediatric ADHD Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Curemark Pediatric ADHD Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Supernus Pharmaceuticals Pediatric ADHD Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
